Estimation of groin recurrence risk in patients with squamous cell vulvar carcinoma by the assessment of marker gene expression in the lymph nodes

Table 1 Individual patient data

Patient No.	Age (years)	TNM Stage	Histological Grade	Histological subtype	HPV Status/Type	Groin recurrence
5	59.3	T2N0M0	n.d.	K	n.d.	occurred
7	81.3	T2N1M0	G2	K	n.d.	occurred
8	61.0	T2N1M0	G2	K	n.d.	occurred
15*	77.2	T2N2M0	G2	K	negative	occurred
18	78.3	T3N2M0	G1	nK	negative	not observed
19	51.1	T2N1M0	G3	nK	negative	not observed
21*	93.9	T2N1M0	G2	K	negative	not observed
23	71.5	T2N1M0	G2	K	negative	not observed
25	75.3	T2N0M0	G1	K	negative	not observed
26	56.8	T2N0M0	G1	K	negative	not observed
30	45.3	T2N0M0**	G3	nK	HPV16	not observed
34	71.2	T2N1M0	G2	nK	negative	not observed
41	80.6	T2N1M0	G1	K	negative	occurred
45	76.1	T2N0M0	G3	nK	negative	not observed
46*	64.5	T2N1M0	G3	K	negative	occurred
49	76.0	T2N0M0	G3	nK	negative	occurred
51	56.7	T2N2M0	G3	K	negative	occurred
53	70.3	T2N0M0**	G2	K	negative	occurred
58	52.4	T1bN2M0	G2	K	negative	not observed
61*	76.6	T2N1M0	G2	nK	negative	not observed

Abbreviations: K - keratinising squamous cell carcinoma; nK - non-keratinising squamous cell carcinoma; n.d. - not determined; *- LNs of these patients were incorporated into microarray analysis, **- patients subjected to the unilateral lymphadenectomy.

ISSN: 1471-2407